Health

Global Veterinary Therapeutics Market is Growing at 6.0% CAGR During 2017 to 2026

MarketResearch announces publication of its most recently generated research report titled, “Global Veterinary Therapeutics Market by types, end user, and region – Global Forecast to 2026”, which offers a holistic view of the global veterinary therapeutics market through systematic segmentation that covers every aspect of the target market. According to the forecast projections, revenue from the global veterinary therapeutics market is expected to expand at a moderate CAGR of 6.0% during the forecast period.

According to library automation service systems market infographics: Global Veterinary Therapeutics Market: Segmental Snapshot

The market report has been segmented on the basis of types, end user, and region.The type segments include Therapeutics drugs, Therapeutics vaccines, Feed additives therapeutics. End-user segments include Hospitals, Veterinary Clinics, Drugs Stores. The regions and countries covered in the analysis are North America, Europe, Asia Pacific, Latin America, and Rest of the World.

READ ALSO:  10 Fun Facts about Flossing

The therapeutics drugs segment in the global veterinary therapeutics market is estimated to account for major revenue share of 55.6% in 2017.

Key Players: Bayer AG, Boehringer Ingelheim GmbH, Ceva Inc, Dechra Pharmaceuticals PLC, Vetoquinol SA, Zoetis Inc, Virbac SA, Eli Lilly and Company, Merck Co Inc.

Global Veterinary Therapeutics Market is Growing at 6.0% CAGR During 2017 to 2026

Source of Infographics: Veterinary Therapeutics Market Infographics by MarketResearch

 

Loading

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x